News

As per the terms of the agreement, Merck, through a subsidiary, will initiate a tender offer for all outstanding common stock of Inspireat a price of $5 per

Aragen Bioscience has received three subcontracts to produce and characteriza stable cell lines expressing antibodies against polio virus, pandemic influenza virus and Candida albicans, and to develop cell

The newly-issued patent relates to the GeNO cartridge technology that eliminates nitrogen dioxide (NO2) from the gas being delivered to the patient. Out of two Phase 2 trials,

Pursuant to the proposed merger, Evolva is expected to take over 100% of the share capital of Abunda in return for 25m Evolva shares (12.9% of Evolva’s share

Abstral , which is already marketed by ProStrakan across the European markets has got the US Food and Drug Administration approval in January 2011. Abstral is based on

As per the terms of the agreement, Neomycin Sulfate tablets will be manufactured by Oman Pharma, and marketed and distributed by Breckenridge on an exclusive basis in the

Tafamidis is an oral experimental compound which is used to treat the patients who are suffering from Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP). FDA said the NDA which was

Prior to Daiichi Sankyo, Gargiulo worked as the senior vice president of Commercial Operations where he was responsible for the company’s US marketing, Supply Chain, Managed Markets and

TX-RAD is a type 1 regulatory T cell based immunotherapy used for the treatment of joint inflammatory diseases like rheumatoid arthritis. The study RATS1 (Rheumatoid arthritis And Tr1